Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NDAC To Assess Risks, Efficacy Of Antiseptic Hand Wash Products

This article was originally published in The Tan Sheet

Executive Summary

The risks and benefits of consumer antibacterial hand and body wash products will be considered by the Nonprescription Drugs Advisory Committee at a meeting slated for Oct. 20 & 21
Advertisement

Related Content

Antiseptic Products “Not Effective” In Reducing Skin Infection – FDA
Antiseptic Products “Not Effective” In Reducing Skin Infection – FDA
Antiseptic Products “Not Effective” In Reducing Skin Infection – FDA
Antiseptic Log Reduction Criteria Should Stand, NDAC Recommends
TOPICAL ANTIMICROBIAL "BROAD SPECTRUM ACTIVITY" DEFINITION ADDED
TOPICAL ANTIMICROBIAL "BROAD SPECTRUM ACTIVITY" DEFINITION ADDED
HEALTH CARE ANTISEPTICS TFM INCLUDES FIVE CATEGORY I INGREDIENTS

Topics

Advertisement
UsernamePublicRestriction

Register

PS098656

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel